Joint Corp (NASDAQ:JYNT) insider David M. Orwasher sold 4,200 shares of the business’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $3.01, for a total transaction of $12,642.00. Following the transaction, the insider now owns 127,723 shares in the company, valued at $384,446.23. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Joint Corp (NASDAQ:JYNT) traded up 0.34% during midday trading on Thursday, hitting $2.93. 27,380 shares of the company traded hands. Joint Corp has a 12-month low of $1.85 and a 12-month high of $7.90. The stock’s 50-day moving average is $2.37 and its 200-day moving average is $2.97. The firm’s market capitalization is $37.30 million.
Joint Corp (NASDAQ:JYNT) last announced its quarterly earnings data on Thursday, August 11th. The company reported ($0.26) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.27) by $0.01. The business earned $5 million during the quarter, compared to analyst estimates of $3.40 million. Analysts anticipate that Joint Corp will post ($0.97) EPS for the current fiscal year.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/08/joint-corp-jynt-insider-david-m-orwasher-sells-4200-shares.html
Several equities analysts have recently commented on the stock. Zacks Investment Research upgraded shares of Joint Corp from a “hold” rating to a “buy” rating and set a $2.25 price target on the stock in a report on Wednesday, August 17th. Maxim Group lowered their price target on shares of Joint Corp from $8.00 to $5.00 and set a “buy” rating on the stock in a report on Friday, July 1st. Finally, Feltl & Co. cut shares of Joint Corp from a “strong-buy” rating to a “buy” rating in a report on Friday, June 24th.
Joint Corp Company Profile
The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.
Receive News & Ratings for Joint Corp Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Joint Corp and related companies with MarketBeat.com’s FREE daily email newsletter.